SCHEMBL13811571

SCHEMBL13811571

CCN(CC)CCOc1nc2c(c(-c3ccc(OC)c(OC)c3)n1)C(C#N)CN2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.41
ADORA2A P29274 2/20 0.39
ADORA1 P30542 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
PSMD14 O00487 1/20 0.35
APAF1 O14727 1/20 0.35
RAD52 P43351 1/20 0.35
UBE2N P61088 1/20 0.35
KMT2A Q03164 1/20 0.35
PLEC Q15149 1/20 0.35
SAE1 Q9UBE0 1/20 0.35
UBA2 Q9UBT2 1/20 0.35
PDE4B Q07343 2/20 0.35
MCHR1 Q99705 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13811528 0.80 HSP90AB1 (0.42) HSP90AB1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL13811572 0.75 HSP90AB1 (0.44) HSP90AB1TDP1PDE4B
SCHEMBL13811568 0.74 ADORA2A (0.39) HSP90AB1ADORA2AADORA1KDM4E
SCHEMBL12161119 0.73 HSP90AB1 (0.69) HSP90AB1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL13811668 0.68 HSP90AB1 (0.59) HSP90AB1ADORA1
SCHEMBL13811670 0.68 HSP90AB1 (0.61) HSP90AB1
SCHEMBL10358080 0.61 MAPT (0.56) KDM4EPOLBKMT2AMCHR1MAPT
SCHEMBL8138601 0.60 WHR1 (0.42) KDM4EALDH1A1POLBGAAHPGD
SCHEMBL12160978 0.60 HSP90AB1 (0.91) HSP90AB1
SCHEMBL13544233 0.60 SQOR (0.39) KDM4EALDH1A1GAAHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163490-A1 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors VERNALIS (R&D) LTD. (GB) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163490-A1 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors HSP90AA1, HSP90AB1, RAF1 HSP90AB1 2/4885ADORA2A 2485/4885ADORA1 2088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.